About Immedica
Immedica is a company based in Stockholm (Sweden) founded in 2017 was acquired by KKR in April 2024.. Immedica has completed 2 acquisitions, including Marinus Pharma and Neurocrine. Immedica operates in a competitive market with competitors including AmerisourceBergen, Daiichi Sankyo, Beactica, Asgard Therapeutics and Alligator Bioscience, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
KKR
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Marinus Pharma
& 1 more
-
Acquired by
KKR
(Apr 23, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Immedica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Immedica
Immedica has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include KKR and Impilo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Impilo is focused on healthcare investments in Nordic regions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Immedica
Immedica has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Marinus Pharma and Neurocrine. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of therapeutics to treat seizure disorders
|
2003 | ||||
|
Developer of small molecule therapeutics for endocrine and CNS disorders
|
1992 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Immedica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immedica Comparisons
Competitors of Immedica
Immedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Daiichi Sankyo, Beactica, Asgard Therapeutics and Alligator Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical drugs are developed to address diverse medical needs.
|
|
| domain | founded_year | HQ Location |
Develops small molecule drugs for oncology
|
|
| domain | founded_year | HQ Location |
Cancer immunotherapies are developed via direct cell reprogramming techniques.
|
|
| domain | founded_year | HQ Location |
Alligator Bioscience is focused on tumor-directed cancer immunotherapy development.
|
|
| domain | founded_year | HQ Location |
Personalized immunotherapeutics are developed for oncology and autoimmune diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Immedica
Frequently Asked Questions about Immedica
When was Immedica founded?
Immedica was founded in 2017.
Where is Immedica located?
Immedica is headquartered in Stockholm, Sweden.
Who is the current CEO of Immedica?
Anders Edvell is the current CEO of Immedica.
What does Immedica do?
Immedica was founded in 2017 in Stockholm, Sweden, as a developer of therapeutic agents targeting oncology, neurology, infectious diseases, ophthalmology, and inflammatory conditions. Drugs such as Arlevert and Vertisan have been created for vertigo treatment across various origins, while additional agents address corneal neovascularization. Operations focus on pharmaceutical innovation within these medical sectors.
Who are the top competitors of Immedica?
Immedica's top competitors include AmerisourceBergen, Daiichi Sankyo and Alligator Bioscience.
How many acquisitions has Immedica made?
Immedica has made 2 acquisitions, including Marinus Pharma, and Neurocrine.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.